Pfizer Must Face Trimmed Robitussin Labeling Suit
Pharmaceutical giant Pfizer won the partial dismissal of a proposed class action in New York federal court Monday accusing it of misleading consumers with its "Maximum Strength" labeling of Robitussin cough...To view the full article, register now.
Already a subscriber? Click here to view full article